Cell Transformation, Neoplastic

The grounding supports a multifactorial origin involving both genetic and environmental influences in carcinogenesis. Neoplastic transformation is described as a multistage process driven by progressive mutations and epigenetic alterations in gene expression. It is also covered as chemically induced and in relation to drug effects, but no specific causal agents are provided.

The literature grounding points to dysregulated signal transduction, altered gene expression regulation, epigenetic change, and increased cell proliferation and survival as core mechanisms. Co-studied pathways and proteins include receptor tyrosine kinases, ErbB receptors, trkB, phosphatidylinositol 3-kinases, proto-oncogene proteins, and cytokines, indicating growth and survival signaling abnormalities. The tumor microenvironment, epithelial-mesenchymal transition, and immune escape also contribute to invasive and metastatic behavior.

Risk is increased by environmental factors and genetic factors, as supported by the gastric cancer review. The literature also indicates age as a risk-associated factor in gastric cancer, with incidence rising progressively with age. No broader disease-specific risk factors are supported in the supplied grounding.

The supplied grounding does not provide a disease-specific standard treatment for neoplastic cell transformation itself. It does support treatment concepts at the modality and drug-class level in cancer more broadly, including targeted therapy approaches such as EZH2 inhibitors and therapies directed at signaling pathways and the tumor microenvironment. Immunologic and metabolic targets are also discussed as therapeutic strategies, but no specific standard regimen is given.